Original Article
Convalescent Plasma Therapy in Late-State, Severe COVID-19 Infection
Objectives: Current evidence favors plasma to be effective against coronavirus disease 2019 (COVID-19) in critically ill patients in the early stages of infection. We investigated the safety and efficacy of convalescent plasma in specifically late-stage (designated as after 2 weeks of hospital admission) severe COVID-19 infection. We also conducted a…
Posted in:
COVID-19 55 late stage 2